The people shaping biopharma
Conversations on the people, ideas and decisions shaping biopharma.
Featured interview · November 2026
Jeremy Levin believes drugmakers owe a duty to the public, not just shareholders. In an interview with Henri Mattila, the seasoned executive and entrepreneur says Washington should take a page from Beijing’s strategic playbook if it wants the United States to remain a leader in medical innovation.
Read the interviewInvesting perspective
On the harder path of biotech investing, why medicines endure, and what actually bottlenecks AI in drug discovery.
Policy corner
How a philanthropy shapes health policy without advocating for it, and where affordability and transparency go next.
February 2026
The physician and economist, formerly a professor at Stanford, now leads the world’s largest funder of biomedical research.
May 2024
A leader at the intersection of technology and healthcare on the promise and peril of social media, artificial intelligence, and the misinformation that travels faster than the facts.
February 2024
On growing up amid war, why healthcare has no equivalent of a nutrition label, and what it would take to hand the money back to the people who already pay for it.
September 2022
For all the attention paid to America’s fading competitiveness in a globalized economy, there is one sector where the United States still reigns supreme.
Stay informed